<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 22 Jun 2026 08:32:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  DEF 14A    Vicarious Surgical Inc.   For: Jul 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Vicarious+Surgical+Inc.+++For%3A+Jul+21/26670456.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26670456.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Vicarious+Surgical+Inc.+++For%3A+Jul+21/26670456.html</guid>
   <pubDate>Mon, 22 Jun 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    Vicarious Surgical Inc.   For: Jul 21</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Vicarious+Surgical+Inc.+++For%3A+Jul+21/26670456.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26670456.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Vicarious+Surgical+Inc.+++For%3A+Jul+21/26670456.html</guid>
   <pubDate>Mon, 22 Jun 2026 08:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  PRE 14A    Vicarious Surgical Inc.   For: Jun 12</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Vicarious+Surgical+Inc.+++For%3A+Jun+12/26640979.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640979.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Vicarious+Surgical+Inc.+++For%3A+Jun+12/26640979.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  PRE 14A    Vicarious Surgical Inc.   For: Jun 12</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Vicarious+Surgical+Inc.+++For%3A+Jun+12/26640979.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26640979.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Vicarious+Surgical+Inc.+++For%3A+Jun+12/26640979.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., May  13, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of a full-day synthetic abdominal model lab demonstrating sustained system performance and continued procedural workflow progression for the Vicarious Surgical System.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;During the lab, the Vicarious Surgical System operated fully draped for multiple hours while our CMO, Dr. Barry Greene, an experienced abdominal surgeon, performed back-to-back IPOM+ and robotic transabdominal preperitoneal (rTAPP) ventral hernia repair workflows. The lab was conducted using the Company’s integrated</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Demonstrates+Sustained+System+Performance+and+Complex+Hernia+Procedure+Workflows+in+Pre-Clinical+Setting/26482757.html</guid>
   <pubDate>Wed, 13 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Inc. (RBOT) Misses Q1 EPS by 103c</title>
   <link>http://www.streetinsider.com/Earnings/Vicarious+Surgical+Inc.+%28RBOT%29+Misses+Q1+EPS+by+103c/26401764.html</link>
   <description>&lt;p&gt;Vicarious Surgical Inc. (NYSE: RBOT) reported Q1 EPS of ($1.03).&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Vicarious Surgical Inc. (RBOT) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=RBOT&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Vicarious+Surgical+Inc.+%28RBOT%29+Misses+Q1+EPS+by+103c/26401764.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:59:42 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  10-Q       Vicarious Surgical Inc.   For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Vicarious+Surgical+Inc.+++For%3A+Mar+31/26401553.html</link>
   <description>si-local-file:///var/storage/secattach/20260430/26401553.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Vicarious+Surgical+Inc.+++For%3A+Mar+31/26401553.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  10-Q       Vicarious Surgical Inc.   For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Vicarious+Surgical+Inc.+++For%3A+Mar+31/26401553.html</link>
   <description>si-local-file:///var/storage/secattach/20260430/26401553.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Vicarious+Surgical+Inc.+++For%3A+Mar+31/26401553.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Vicarious Surgical Reports First Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;WALTHAM, Mass., April  30, 2026  (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;First Quarter 2026 Financial Results&lt;/strong&gt;&lt;/p&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Total operating expenses were $7.5 million in the first quarter of 2026, compared to $15.7 million in the first quarter of 2025, a decrease of 52%.&lt;/li&gt;&lt;/ul&gt;  &lt;ul&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;Research and development expenses in the first quarter of 2026 were $5.0 million, compared to $9.4 million</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vicarious+Surgical+Reports+First+Quarter+2026+Financial+Results/26401452.html</guid>
   <pubDate>Thu, 30 Apr 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.10710336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02826370</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  8-K        Vicarious Surgical Inc.   For: Apr 08</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vicarious+Surgical+Inc.+++For%3A+Apr+08/26289690.html</link>
   <description>si-local-file:///var/storage/secattach/20260408/26289690.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vicarious+Surgical+Inc.+++For%3A+Apr+08/26289690.html</guid>
   <pubDate>Wed, 08 Apr 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
  <item>
   <title>Form  8-K        Vicarious Surgical Inc.   For: Apr 08</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vicarious+Surgical+Inc.+++For%3A+Apr+08/26289690.html</link>
   <description>si-local-file:///var/storage/secattach/20260408/26289690.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vicarious+Surgical+Inc.+++For%3A+Apr+08/26289690.html</guid>
   <pubDate>Wed, 08 Apr 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50272814</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RBOT</category>
   	  </item>
 </channel>
</rss>
